Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity. [PDF]
Mengarda AC +4 more
europepmc +1 more source
Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents. [PDF]
Sánchez-Palestino LM +10 more
europepmc +1 more source
Ruthenium Complexes Containing Thiobenzamide Act as Potent and Selective Anti-<i>Trypanosoma cruzi</i> Agents through Apoptotic Cell Death. [PDF]
das Neves MVG +11 more
europepmc +1 more source
Harnessing Phytonanotechnology to Tackle Neglected Parasitic Diseases: Focus on Chagas Disease and Malaria. [PDF]
García M, Magi MS, García MC.
europepmc +1 more source
Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (<i>Trypanosoma cruzi</i> and <i>Leishmania mexicana</i>) and Anti-<i>Mycobacterium tuberculosis</i> Agents. [PDF]
Delgado-Maldonado T +13 more
europepmc +1 more source
Potent kinase inhibitors from the Merck KGaA OGHL: Novel hits against Trypanosoma brucei with potential for repurposing. [PDF]
Dize D +6 more
europepmc +1 more source
Effect of <i>Euterpe oleracea</i> Mart. (Açaí) Seed Bioproducts on <i>Trypanosoma cruzi</i>. [PDF]
Previtalli-Silva H +8 more
europepmc +1 more source
Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against <i>Trypanosoma cruzi</i> and <i>Leishmania mexicana</i>. [PDF]
Navarrete-Carriola DV +8 more
europepmc +1 more source
Gossypol: a potential trypanocidal agent Gossypol: um agente potencialmente tripanocida
openaire +1 more source
Statins do not reduce the parasite burden during experimental <i>Trypanosoma cruzi</i> infection. [PDF]
Razzaq S +7 more
europepmc +1 more source

